IL6 and early-onset autosomal dominant Alzheimer disease: More recently, it was reported that treatment with Tan IIA reduced the expression of proinflammatory cytokines such as NF-κB, TNF-α, IL-6, and IL-1β in Alzheimer's disease model [27,28].